Skip to main content

Table 4 Multivariable binary logistic regression analysis showing factors associated with good adherence

From: The role of ambulatory blood pressure monitoring in enhancing medication adherence among patients with newly diagnosed hypertension: an analysis of the National Health Insurance cohort database

Variable

OR (95% CI)

P value

With ABPM

2.35 (2.28–2.41)

< 0.001

Age, years

 ~ 29

0.18 (0.16–0.19)

< 0.001

 30 ~ 39

0.48 (0.45–0.50)

< 0.001

 40 ~ 49

0.76 (0.73–0.79)

< 0.001

 50 ~ 59

0.88 (0.85–0.90)

< 0.001

 60 ~ 69

1 (reference)

-

 70 ~ 79

0.85 (0.82–0.89)

< 0.001

 80 ~ 

0.52 (0.49–0.56)

< 0.001

Dyslipidemia

0.96 (0.93–0.99)

0.015

Ischemic heart disease

1.07 (1.01–1.13)

0.035

Myocardial infarction

1.30 (1.03–1.65)

0.028

Anti-platelets

1.07 (1.02–1.13)

0.009

Anti-diabetics

1.15 (1.10–1.21)

< 0.001

Statins

1.10 (1.05–1.16)

0.001

AHM number

 0 ~  < 1

0.89 (0.85–0.93)

< 0.001

 1

1 (reference)

-

 1 ~  < 2

1.82 (1.77–1.88)

< 0.001

 2 ~  < 3

2.09 (2.01–2.18)

< 0.001

 3 ~  < 4

2.29 (2.15–2.44)

< 0.001

 ≥ 4

2.67 (2.15–2.44)

< 0.001

Daily dosing frequency of AHM

 ≤ 1

1 (reference)

 

 1 <  ~  < 2

0.67 (0.65–0.69)

< 0.001

 ≥ 2

0.35 (0.34–0.37)

< 0.001

  1. ABPM ambulatory blood pressure, AHM anti-hypertensive medication, OR odds ratio, CI confidence interval